Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMRI vs. Ultrasound for HCC Surveillance in Cirrhosis
NCT04288323Phase 4Completed
- Sponsor
- University of California, San Diego
- Start
- Apr 2018
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gadoxetate disodium in hepatocellular carcinoma (HCC), sponsored by University of California, San Diego. Started Apr 2018; status: completed.
02
Drugs
gadoxetate disodium
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT04288323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04288323.